Clinical trial
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's…
NCT00335153 · AbbVie (prior sponsor, Abbott), Industry · Completed
Key facts
| NCT number | NCT00335153 |
|---|---|
| Title | Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease |
| Official title | An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications |
| Lead sponsor | AbbVie (prior sponsor, Abbott), Industry |
| Collaborators | Quintiles, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Parkinson's Disease |
| Intervention type | Device, Drug |
| Interventions | Levodopa-carbidopa intestinal gel, CADD-Legacy® 1400 ambulatory infusion pump, PEG tube, J-tube |
| Enrollment | 354 |
| Start date | Jan 1, 2008 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Jun 9, 2006 |
| Last update posted | Jan 16, 2015 |
| Countries | Australia, Canada, Czechia, Finland, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Russia and 4 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: